Special Issue "Epidemiology and Prevention of Vaccine Preventable Diseases"
Deadline for manuscript submissions: closed (1 April 2023) | Viewed by 5915
Interests: health surveillance and promotion; molecular epidemiology; SARS-CoV-2; influenza; HIV; sexually transmitted infections; viral hepatitis infectious disease epidemiology; outbreak investigation; immunizations; epidemiology; antibiotic resistance; vaccine-preventable; infections; foodborne diseases; vector-borne disease; the effectiveness of vaccines; communication on vaccines and vaccinations
Since the diffusion of SARS-CoV-2 infection outside China in 2019, the world has experienced the worst health crisis of the past few decades. SARS-CoV-2’s spread has caused a change in the epidemiology of many pathogens, such as influenza viruses. The COVID-19 pandemic risks disrupting routine immunization activities, causing a drop in vaccine coverage worldwide. Moreover, the war in Ukraine also represents a public health threat in Europe and could trigger the diffusion of VPDs and the occurrence of outbreaks. Any disruption of immunization services could lead to an accumulation of susceptible individuals and an increased risk of outbreaks caused by vaccine-preventable diseases (VPDs).
The Special Issue “Epidemiology and Prevention of Vaccine-Preventable Diseases”, will collect articles in the field of the epidemiology of infectious diseases, including biomedical, environmental, and clinical aspects, and developments of new preventive strategies to increase and maintain a high level of vaccine coverage rates, including sociobehavioral, economic, and communicative aspects.
You are welcome to send short papers, original articles, and reviews for submissions to the Editorial Office for evaluation of their suitability.
Dr. Daniela Loconsole
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Infectious Disease Reports is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- infectious disease
- vaccine coverage
- preventive strategies